Importance of implantable cardioverter‐defibrillator back‐up in cardiac resynchronization therapy recipients: a systematic review and meta‐analysis

S Barra, R Providência, A Tang, P Heck… - Journal of the …, 2015 - Am Heart Assoc
Background It remains to be determined whether patients receiving cardiac
resynchronization therapy (CRT) benefit from the addition of an implantable cardioverter …

[HTML][HTML] A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure

F Tomini, F Prinzen, ADI van Asselt - The European Journal of Health …, 2016 - Springer
Objectives Cardiac resynchronization therapy with a biventricular pacemaker (CRT-P) is an
effective treatment for dyssynchronous heart failure (DHF). Adding an implantable …

Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA …

G Morani, M Gasparini, F Zanon, E Casali, A Spotti… - Europace, 2013 - academic.oup.com
Aims In candidates for cardiac resynchronization therapy (CRT), the choice between
pacemaker (CRT-P) and defibrillator (CRT-D) implantation is still debated. We compared the …

Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy

S Barra, KL Looi, PR Gajendragadkar, FZ Khan… - EP …, 2016 - academic.oup.com
Abstract Aims The Goldenberg risk score, comprising five clinical risk factors (New York
Heart Association class> 2, atrial fibrillation, QRS duration> 120 ms, age> 70 years, and …

Cardiac resynchronisation therapy: pacemaker versus internal cardioverter-defibrillator in patients with impaired left ventricular function

KL Looi, PR Gajendragadkar, FZ Khan, M Elsik… - Heart, 2014 - heart.bmj.com
Objective Studies have shown beneficial effects of cardiac resynchronisation therapy (CRT)
on mortality among patients with heart failure. However the incremental benefits in survival …

Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non …

CT Witt, MB Kronborg, EA Nohr, PT Mortensen… - Europace, 2016 - academic.oup.com
Aims Cardiac resynchronization therapy (CRT) improves symptoms, left ventricular function,
and survival in patients with heart failure (HF) and wide QRS. The benefit of adding …

Cardiovascular implantable electronic device infective endocarditis

M Scarano, F Pezzuoli, G Torrisi… - International …, 2014 - internationaljournalofcardiology.com
Despite the progress in its knowledge and treatment, infective endocarditis remains a
therapeutic challenge [1–7]. Multislice computed tomography and echocardiographic …

Survival and Heart Failure Hospitalization in Patients With Cardiac Resynchronization Therapy With or Without a Defibrillator for Primary Prevention in Japan …

H Yokoshiki, A Shimizu, T Mitsuhashi… - Circulation …, 2017 - jstage.jst.go.jp
Background: Randomized control trials comparing the effectiveness of cardiac
resynchronization therapy devices, with (CRT-D) or without (CRT-P) a defibrillator, are …

Severe staphylococcal sepsis in patient with permanent pacemaker

GM Calvagna, S Patanè - International …, 2014 - internationaljournalofcardiology.com
The use of implantable cardiac devices has increased in the last 30 years. The evolution of
devices in serious cardiac rhythm pathology management has led progressively to the …

[HTML][HTML] Mapping the research trends and hot topics of ventricular arrhythmia: A bibliometric analysis from 2001 to 2020

S Wang, T Jia, G Liu, X Lu, Q Yang… - Frontiers in Cardiovascular …, 2022 - frontiersin.org
Background Studies of ventricular arrhythmia (VA) have drawn much scholarly attention over
the past two decades. Our study aimed to assess the current situation and detect the …